Rhinovirus 3C protease is an attractive target For therapeutic intervention owing to its important role in virion maturation and inFectivity. In order to Facilitate the identification of potential 3C protease inhibitors, we have developed a continuous Fluorescence assay using 5-[(2-aminoethyl}amino]naphthalene-l-sulphonic acid (Edans) as a Fluorescent donor and 4-(4-dimethylaminophenyl-azo}benzoic acid (Dabcyl) as a quenching acceptor. Several F1uorogenic peptide substrates For 3C protease were synthesized by both solution chemistry and solid phase peptide synthesis. One of the synthetic Edans/ Dabcyl substrates, with an amino acid sequence derived From the 2C/3A site of the virus polyprotein, yielded a 24-Fold increase in Fluorescence intensity after 3C cleavage. Data regarding substrate cleavage kinetics, assay sensitivity and optimization are presented. The application ofthisassay to the evaluation of 3C protease inhibitors is also shown.
Introduction
Many positive-stranded RNA viruses translate their genetic information into a large polyprotein precursor which is subsequently processed by virus-encoded proteases to produce various structural proteins and functional enzymes (Couch, 1990) . In the case of human rhinoviruses (HRV), it is believed that the single large protein precursor is processed first by the 2A protease and then by the 3C enzyme at several maturation sites (Palmenberg, 1987; Porter, 1993) . Both 2A and 3C proteins belong to the cysteine protease family of enzymes which contain a nucleophilic cysteine residue at the active site. Site-directed mutagenesis and three-dimensional crystallography of the HRV-14 3C protein have suggested that this enzyme is structurally related to serine proteases and has trypsin-like protein folding (Bazan & Fletterick, 1988; Cheah et al., 1990; Matthews et al., 1994) . In addition, viral3C protein has been shown to form a complex with the 5' non-coding region of the viral RNA and may participate in the initiation of plus-strand viral RNA synthesis (Leong et al., 1993) . Moreover, it has been proposed that this enzyme is involved in the inhibition of host cell RNA transcription and protein translation during viral infection (Porter, 1993) .
Since the maturational proteolytic process is an essential step in the formation of infectious virus particles, inhibition of viral proteases responsible for this event has become an important focus for the development of antivi-ral therapeutics. For HRV 3C protease, its important function in the virus life-cycle and unique protein structure, with no known cellular homologues, make it an excellent target for antiviral drug design. Development of novel inhibitors against 3C protease requires an accurate and sensitive enzyme assay suitable for both high capacity screening and enzyme inhibition kinetic studies. A wide range of techniques have previously been used for measurement of HRV-14 3C activity in vitro. These include (i) an in vitro translation assayusing viral polyprotein fragments as substrate (Heinz et al, 1996) ; (ii) HPLC methods with small synthetic peptides as substrates Long et al, 1989; Cordingley et al., 1990) ; and (iii) a magnetic bead assay using radiolabelled peptide (Wu & Abeles, 1995) . The availability of these methods has greatly facilitated our understanding of viral 3C protease, especiallywith respect to its substrate specificity and amino acid preferences.These assaying methods, however, are not adequate for high throughput screening owing to their laborious and time consuming procedures. Recently, Birch et al. (1995) reported a continuous fluorescenceassay using anthranilyl peptide substrate to detect HRV-14 3C protease. However, high background activitywas observed with the uncleaved substrate, caused by the insufficient collisional quenching by p-nitrophenylalanine. To date, a fluorescence assay based on efficient resonance energy transfer has not been used for HRV 3C protease, although a number of quenched substrates based on this mechanism have been described for several other viral proteases (Matayoshi et al., 1990; Handa et al., 1995; Holskin et al, 1995) . The fluorescence donorlquencher pair described in these reports are donor 5-[(2-aminoethyl)amino]naphthalene-l-sulphonic acid (Edans) and quencher 4-(4-dimethylaminophenylazo)benzoic acid (Dabcyl). Cleavage of an Edans/Dabcyl peptide by a proper protease eliminates intramolecular quenching and thus results in a significant fluorescenceincrease which can be continuously monitored by a fluorometer. In order to develop a high-throughput protease assay to search for potential HRV 3C enzyme inhibitors, we have established an EdansIDabcyl fluorescence peptide assay for this enzyme. Reported here is the fluorogenic peptide synthesis, substrate evaluation, assay optimization and its application to 3C protease inhibitor screening.
Materials and Experimental Procedures: Chemistry

Materials
All standard Fmoc amino acids and resins were obtained from Applied Biosystems (Foster City, Calif, USA). Dabcyl was obtained from Sigma and Edans was received from Lancaster (Windham, N.H., USA).
Preparation of Dabcyl-gaba-HN-ETLFQGPVY-CO-Edans
To a solution of H 2N-ETLFQGPVY-C02H (49 mg, 0.046 mmol) in dry DMF (6 mL) was added Dabcylgaba-NHS (Wang et al., 1993) (30 mg, 0.066 mmol) followed by triethyl amine (0.2 mL, excess).The mixture was stirred overnight at room temperature and the DMF was then removed in vacuo.The resulting residue was triturated with methylene chloride and the insoluble material was collected by filtration and washed with methylene chloride until the filtrate was colourless.The resulting redorange solid was dried in vacuo to give 54 mg of Dabcylgaba-HN-ETLFQGPVY-C0 2H (analytical HPLC indicated this material was over 95% pure; C-18 ubondapak column, eluted with 50% CH 3CN and 0.1%TFNH 20 at 2.8 min). This Dabcyl-modified peptide (54 mg), Edans (17 mg), NHS (10 mg, excess) and EDC (25 mg, excess) were dissolved in dry DMF (10 mL) and the resulting mixture was stirred at room temperature overnight. The reaction mixture was concentrated to an orange glass, dissolved in a mixture ofCH 3CN, H 20 and DMF and then loaded onto a preparative HPLC column (Waters Prep 4000 system; C-18 j.lbondapakcolumn). The column was eluted with 35% CH 3CN and 0.1%TFNH 20 to give two fractions. The first peak to elute provided 22 mg of a red solid which, by mass spectrometry analysis (molecular weight 1885), was the product resulting from incorporation of 2 mol Edans: Dabcyl-gaba-HN-E(Edans)-TLFQGPVY-CO-Edans (peptide 3; analytical HPLC indicated this material was >95% pure; C-18 ubondapak column, eluted with 40% CH 3CN and 0.1%TFNH 20 at 2.9 min). A more slowly eluting fraction (retention time 7.1 min) was also collected to give approximately 10 mg of a red solid. Mass spectrometry analysis (M+l=1637) was consistent with the desired Dabcyl-gaba-HN-ETLFQG-PVY-CO-Edans (peptide 1) or Dabcyl-gaba-HN-E(Edans)TLFQGPVY-C0 2H (peptide 2).
Preparation of Dabcyl-gaba-HN-QALFQGPVY-CO-Edans
To a solution of H 2N-QALFQGPVY-C02H (42 mg, 0.041 mmol) in dry DMF (6 mL) was added Dabcylgaba-NHS (Wang etal., 1993) (30 mg, 0.066 mmol) followed by triethyl amine (0.2 mL, excess). The mixture was stirred overnight and processed as described above. The resulting material was dried in vacuo to give 42 mg of Dabcyl-gaba-HN-QALFQGPVY-C0 2H.
Dabcyl-gaba-HN-Qb.LFQGPVY-C0 2H (40 mg, 0.029 mmol), Edans (13 mg, 0.045 mmol), NHS (10 mg, excess) and EDC (20 mg, excess) were dissolved in dry DMF (6 mL) and the resulting mixture was stirred at room temperature overnight, concentrated to a volume of approximately 3 mL and loaded directly onto the preparative HPLC column. The column was eluted with a step gradient of 0-50% CH 3CN and 0.1% TFNH 20 to give 4.5 mg of pure Dabcyl-gaba-HN-QALFQGPVY-CO-Edans (peptide 4) as a red solid (analytical HPLC indicated this material was >94%pure; C-18 flbondapak column, eluted with 45% CH 3CN and 0.1% TFNH 20 at 3.0 min).
Preparation of AcHN-SLE(Edans)ALFQGPVYK-(Dabcyl)-CONH 2
To a solution of AcHN-SLEALFQGPVYK-CONH 2 (27 mg, 0.019 mmol) in dry DMF (5 mL) was added Dabcyl-NHS (Wang et a/., 1993) (10 mg, 0.027 mrnol) followed by triethyl amine (0.1 mL, excess). The mixture was stirred overnight at room temperature. Using similar procedures as those described above, 27 mg of AcHN-SLEALFQG-PVYK(Dabcyl)-CONH 2 was obtained as a red-orange solid (MS: 1644=M+).
AcHN-SLEALFQGPVYK(Dabcyl)-CONH 2 (25 mg, 0.015 mmol), Edans (10 mg, excess),NHS (10 mg, excess) and EDC (20 mg, excess) were dissolved in dry DMF (2 mL) and the resulting mixture was stirred at room temperature overnight and then loaded directly onto the preparative HPLC column. The column was eluted with a step gradient of 0-50% CH 3CN and 0.1% TFNH 20 to give 6 mg of pure peptide 5 as a red-orange solid (analytical HPLC indicated this material was >92% pure; C-18 flbondapak column, eluted with 40% CH 3CN and 0.1% TFNHp at 5.4 min).
Synthesis of N-a-Fmoc-N-f.-Dabcyl-L-Iysine
The N-a-Fmoc-N-f.-Dabcyl-L-lysine (Lys-Dabcyl) precursor was prepared as described previously (Wang & Krafft, 1992) . Briefly, N-a-Fmoc-lysine (640 mg, 1.52 mmol) and Na 2C03 (160 mg, 1.52 mmol) were dissolved in 70 mL of a 1:1 solution of dioxane and water. A solution of Dabcyl-NHS (544 mg, 1.49 mmol) in 20 mL DMF was then added and the solution was stirred for 24 h at room temperature under N 2 • Then, 1 M HCI (1.7 mL) was added and the contents stirred for 5 min. The solvents were removed in vacuo and the residue was taken up in hot ethyl acetate. The crude product was purified by flash chromatography on a silica gel column. Impurities were eluted first with ethyl acetate. The product was then eluted with a gradient of methanol in ethyl acetate (10,25, 40%, 1 L each) to give 913.1 mg of pure product (98.9% yield).
Synthesis of N-a-Fmoc-L-glutamic acid-y-(Edans) amide (Glu-Edans)
Preparation of Glu-Edans was based on a modification of a previously described procedure (Wang & Krafft, 1992) . To a dry 250 mL flask was added N-Fmoc t-butyl glutamate (1.06 g, 2.5 mmol), EDC (816 mg, 4.3 mmol), NHS (150 mg, 1.3 mmol) and Edans sodium salt (726 mg, 2.52 Antiviral Chemistry &Chemotherapy 8(4) Development of assay for rhinovirus 3C pratease mmol), followed by 100 mL of dry DMF. The solution was stirred at room temperature under a nitrogen atmosphere. When the reaction was complete as indicated by TLC (20% MeOH/EtOAc), the majority of solvent was removed on a rotary evaporator. The crude material was purified by column chromatography using a gradient from o to 20% methanol in ethyl acetate, to yield 1.35 g of N-Fmoc 't:Edans t-butyl glutamate as a yellow solid (78% yield). The t-butyl ester was hydrolysed at room temperature for 2 h by treatment with glacial acetic acid (50 mL) saturated with gaseous HCI. Evaporation of solvents afforded 830 mg of Glu-Edans as a tan solid (69% yield).
Solid-phase peptide synthesis (SPPS)
Peptides were synthesized on Applied Biosystems 431A and 433A peptide synthesizers using Fmoc chemistry with 2-(lH-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) as the amino acid activator. When required, N termini were capped with glacial acetic acid on the synthesizer and C-terminal amides were obtained by cleavage from a modified benzhydrylamine resin. SPPS of Edans-and Dabcyl-containing peptides was performed according to the method of Krafft & Wang (1994) . Manually programmed extended coupling of Lys-Dabcyl and Glu-Edans was not necessarywhen using the feedback monitoring capability of the peptide synthesizer. Cleavage and deprotection was performed with 89% TFA and 11% scavenger cocktail (ethanedithiol: thioanisole:water, 1:2:2) at 25°C for 1 h. Crude peptides were lyophilized and then purified by reversed-phase preparative HPLC using a gradient 0-90% of 70% acetonitrile/0.1% TFA to elute the products from a C-18 or Resource RPC column. Analysis of the purified peptides by HPLC indicated their purities were over 95%. All peptide syntheses were confirmed by mass spectrometry.
Materials and Experimental Procedures: Enzymology
Materials Recombinant HRV-14 3C protease was expressed and purified using the procedures published previously (Birch et al., 1995) . Protease inhibitors were purchased from Sigma.
Fluorescence assay for 3C protease Cleavage reactions (400 flL) were performed at 30°C for the time indicated in a solution of 50 mM Hepes pH 7.5, 150 mM NaCl, 1 mM EDTA, 6 mM DTT and 2.5% DMSO with the fluorogenic substrate and 3C protease. Reactions were started by the addition of substrate. Fluorescence was continuously monitored by excitation at 340 nm and emission at 510 nm at bandwidths of 2.5 nm with a Perkin-Elmer LS50B luminescence spectrometer. DMSO, in which the substrate was dissolved, did not have a significant effect on the 3C protease activity when used at a concentration of 10% or less (approximately 96% of the enzyme activity remained in the assay containing 2.5% DMSO). For protease inhibition studies, at least five different inhibitor concentrations were examined along with the control sample containing no inhibitor under the conditions described above. The 3C protease activity in the presence of the specified inhibitor was expressed as a percentage of that obtained from the respective control samples. For effectors displaying dose-dependent inhibition of the protease activity, IC so values were determined from the plots of the relative protease activity versus inhibitor concentration.
HPLC analysis of protease reaction
3C protease reactions were performed at 30°C in 50 mM Hepes pH 7.5,150 mM NaCI, 6 mM DTT, 1 mM EDTA and 2.5% DMSO with the fluorogenic substrate. Reactions (100 j..LL) were stopped with addition of 100% TCA to a final concentration of 5% and 50 j..tL were injected onto a Shimadzu SCL-10A HPLC. The reaction was eluted from a C-18 column (4.6x250 mrn) at 1 mL min! with a linear gradient of 10-60% acetonitrile/0.1% TFA in 20 min. Peaks were monitored at 214 nm and were collected for further analysis.
Mass spectrometry analysis
Electrospray ionization mass spectrometry was conducted using a PESciex API III triple stage quadrupole mass spectrometer equipped with a pneumatically assisted electrospray (IonSpray) interface. Samples were dissolved in 50:49:1 (v/v/v) acetonitrile:water:acetic acid and were continuously infused into the interface at a rate of 10-20 j..LL min"! using a syringe pump, The instrument was operated in the positive ion detection mode with an IonSpray voltage of 3500 V and an inlet orifice potential of 55 V (+25 V relative to the rod offset voltage). Spectra were collected over a range of300-2000 u at 0.1 u intervals with a dwell time of 1 ms per intervaL A total of 5-10 scans were averaged to yield the final spectrum.
Results
The first internally quenched peptide substrates that we designed were prepared via solution synthesis to incorporate Edans and Dabcyl into the core peptides. A nine amino acid peptide with sequence -ETLFQLGPVY-has been demonstrated to be an excellent substrate for the 3C protease, which cleaves the peptide at the Gln-Gly bond (Cordingley et al., 1990) . Coupling the fluorescence donor and quencher to this peptide was achieved via two-step solution chemistry as previously described (Wang et al., 1993) . The Edans-and Dabcyl-modified peptide 3 was recognized by the 3C protease and a >12-fold increase in fluorescence intensity was observed as a result of the enzyme cleavage (data not shown), indicating that the presence of the bulky aromatic groups of Edans and Dabcyl did not significantly impair the binding of substrate to the enzyme. However, when peptide 3, the major product of synthesis, was analysed by mass spectrometry, it was found to be a bis-Edans amide (Table 1) with one Edans added on the expected C terminus and the other on the second carboxyl group offered by the glutamate at P5, Minor amounts of a mono-Edans-amide, the desired peptide 1, and/or a second unwanted product 2 were also obtained (Table 1) , To avoid this undesired coupling, another two core peptides derived from the same maturation site ofthe HRV-14 polyprotein were prepared for different approaches. One strategy was to replace the charged offending glutamate at P5 with glutamine to avoid multiple addition of Edans, Another strategy employed an endcapped peptide with an amino acid sequence AcNH-SLEALFQLGPVYK-CONH 2 as shown in Table 1 . This peptide was slightly longer than the other two, with a total of 12 amino acids, and had alanine substituted for the original threonine at P4 to increase substrate specificity (Cordingley et al., 1990) . Incorporation of Edans and Dabcyl into these peptides was accomplished by the same protocols. Analyses of these products (peptides 4 and 5) by both HPLC and mass spectrometry confirmed the correct coupling of Edans and Dabcyl, but also revealed their poor solubility (insoluble when assayed at 5 11M or above) in the typical 3C protease reaction solutions.
Since the presence or absence of extra charged groups within the peptides caused either the undesired conjugation of fluorophore or poor substrate solubility, respectively,we decided to utilize automated SPPS to synthesize 3C fluorogenic substrates as described previously for other proteases (Wang & Krafft, 1992; Krafft & Wang, 1994) . Two derived Fmoc-amino acids, Glu-Edans and Lys-Dabcyl, were prepared specially for this strategy by incorporation of Edans and Dabcyl groups into the side chains of glutamic acid and lysine, respectively.To this end, three fluorogenic peptides (peptides 6-8; Table 1 ) were successfully synthesized on a peptide synthesizer using Fmoc chemistry as demonstrated in Fig. 1 . Peptides 6 and 7 were synthesized with a low yield owing to chain termination with loss ofEdans and poor solubility, respectively. Peptide 8, on the other hand, was obtained in a satisfactory yield and exhibited reasonable solubility, which permitted us to conduct further characterization of this method.
Complete hydrolysis of peptide 8 by the 3C enzyme resulted in a 24-fold increase in fluorescence signal, as shown 
Discussion
In this study,we have documented the use of a fluorescencebased peptide assay for measurement of HRV-14 3C in Fig. 2(a) . A progress curve representing the fluorescence intensity change during enzyme-catalysed hydrolysis of peptide 8 is shown (Fig. Za) ; the substrate in the control reaction containing no enzyme was quite stable during the incubation period (data not shown). The fluorescence change as a function of substrate concentration is shown in Fig. 2(b) . The fluorescence increased linearly at low substrate concentration. However, this linearity was lost when the peptide concentration was greater than 15 , owing to the inner filter effect (Holskin et al., 1995) . The hydrolysis rate of peptide 8 at a concentration of 35 11M was linear to the enzyme concentration in the range 0.025 to 0.3 11M (Fig. 2c) , indicating the assay was performed under Michaelis-Menten conditions. Cleavage of peptide 8 by 3C enzyme was also analysed by HPLC. As seen in Fig. 3 , two cleavage products, with retention times of 15.27 and 17.59 min, respectively, were generated from the cleavage reaction, along with a decrease of the original substrate peak at 19.20 min. Since the expected product standards were not available, we decided to isolate these two peaks from the HPLC column and then analyse them by mass spectrometry. The sizes of these two products determined by mass spectrometrywere found to be identical to the calculated ones (data not shown), confirming that the protease cleaved peptide 8 at the expected Gln-Gly bond. Since the measurement of fluorescence change is not always linear to substrate concentration owing to the inner filter effect, as seen in Fig. 2(b) , it is difficult to determine the K m value using this system. With the fluorescence method, however, we obtained the kcalK m ofpeptide 8 for 3C protease as 13 275 M-1 s-l, using substrate concentrations less than 10 11M so as to avoid the inner filter effect.
Application of this fluorescence assay in the evaluation of viral 3C protease inhibitors was demonstrated by testing the effects of some classic protease inhibitors on the 3C protease activity, as shown in Table 2 . Thiol alkylating reagent iodoacetarnide and certain serine/cysteine protease inhibitors such as leupeptin, PMSF and TLCK displayed an inhibitory effect on 3C activity (Table 2) , whereas E-64, a typical papain-like cysteine protease inhibitor, did not inhibit 3C enzyme activity. The 3C inhibition results generated using peptide 8 were consistent with those reported previously using HPLC methods . Taken together, these data indicate that the assay described here is able to recognize 3C enzyme inhibitors and thus can be used for screening potential inhibitors against HRV 3C protease. protease activity in vitro. The sensitivity of this assay relies on the efficient quenching of the Edans fluorescence by the Dabcyl group through resonance energy transfer (Matayoshi et al., 1990; Wu & Brand, 1994) . It has been reported that cleavage of a human immunodeficiency virus protease EdanslDabcyl substrate, separated by eight amino acid residues, with a linear distance of 29 A, causes a >34-fold increase in fluorescence quantum yields (Matayoshi et al., 1990) . More recently, Holskin et al. (1995) reported an EdanslDabcyl substrate for cytomegalovirus protease which had a 10-fold fluorescence increase upon enzyme cleavage. In the case of peptide 8 for viral3C protease, the distance between Edans and Dabcyl, separated by 11 amino acids, was calculated to be 32.6 A and a complete hydrolysis ofthis peptide generated a 24-fold fluorescence intensity increase. The efficient hydrolysis of the peptide by the enzyme along with the observed 24-fold increase in fluorescence empowered this sensitive continuous assay for 3C protease.
Fluorescence assays using the donor!quencher pair Edans/Dabcyl have been described for several viral and non-viral proteases (Matayoshi et al., 1990; Wang et al., 1993; Pennington & Thornberry, 1994; Holskin et al., 1995; Handa et al., 1995) . In most cases, Edans and Dabcyl moieties were placed at the Nand C termini via solution chemistry. This approach has several disadvan-Antiviral Chemistry & Chemotherapy 8(4) tages tn our experience. For example, the presence of charged amino acids within the peptides could complicate solution coupling chemistry, thus additional protection and deprotection of these side groups would be required in order to keep the charged side chains for enhancement of substrate solubility (Pennington & Thornberry, 1994; Holskin et al., 1995; Handa et al., 1995) . Use of automated SPPS methods to synthesize the fluorogenic peptides can minimize these problems. Synthesis of EdanslDabcyl peptides by the SPPS method using Fmoc chemistry has been described in previous reports using a manually programmed extended coupling of Glu-Edans and Lys-Dabcyl (Wang & Krafft, 1992; Krafft & Wang, 1994) . We have simplified the procedure by using the feedback monitoring capability of the synthesizer. This ensures a completely automated procedure for the preparation of Edans/Dabcyl peptides. Since the Glu-Edans and Lys-Dabcyl can be placed at any position of a peptide, this approach offers flexibility in designing and selecting suitable substrates and also permits synthesis of a peptide of any size without necessarily increasing the distance between the fluorophore and quencher, thus reducing the quenching efficiency. Moreover, it allows incorporation of charged amino acids at any position of a peptide in an attempt to increase substrate solubility.
Modification of the original peptides by the Edans and Dabcyl groups was not deleterious to substrate and 3C binding, as indicated by the kcalK m value for peptide 8.
Although fluorescence detection is affected by the inner filter effect, the assay can be performed accurately at low substrate concentrations with high sensitivity (Fig. 2) . The K m value for peptide 8 was estimated to be in the mM range. Thus, conducting the assay with peptide 8 at 35~M or even lower ensures that the substrate concentration is well below the K m . Such conditions are very important for the examination of potential competitive inhibitors of the enzyme because this type of enzyme inhibitor exerts maximum effect only at low substrate concentration (Holskin et al., 1995) .
In summary, we have demonstrated in this report the design, synthesis and characterization of a fluorescencebased assay for the HRV-14 3C protease. This assay is suitable for automated high capacity screening (Matayoshi et al., 1990) and investigation of various types of viral protease inhibitors. The efficient resonance energy transfer between the Edans and Dabcyl groups permits substrates with many residues between the donor/acceptor pair. When combined with the simplified automated synthesis method described herein, various substrates bearing the Edans/Dabcyl groups could be prepared efficiently and provide a sensitive method to study a wide variety of viral or non-viral proteases.
